BeOne Medicines AG
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $4.55B | $2.63B | $3.17B | $3.87B | $4.38B | $1.38B | $618.0M | $712.9M |
| Accounts Receivable | $865.1M | $676.3M | $358.0M | $173.2M | $483.1M | $60.4M | $70.9M | $41.1M |
| Inventory | $608.2M | $495.0M | $416.1M | $282.3M | $242.6M | $89.3M | $28.6M | $16.2M |
| Total Current Assets | $6.23B | $3.99B | $4.20B | $5.21B | $7.61B | $4.96B | $1.17B | $1.94B |
| Property, Plant & Equipment | $1.64B | $1.58B | $1.32B | $845.9M | $587.6M | $357.7M | $242.4M | $157.1M |
| Goodwill | — | — | — | $109.0K | $109.0K | $109.0K | $109.0K | $109.0K |
| Intangible Assets (Excl. Goodwill) | $62.7M | $51.1M | $57.1M | $40.6M | $46.7M | $5.0M | $5.8M | $7.2M |
| Total Assets | $8.19B | $5.92B | $5.81B | $6.38B | $8.54B | $5.60B | $1.61B | $2.25B |
| Liabilities | ||||||||
| Accounts Payable | $479.0M | $405.0M | $315.1M | $294.8M | $262.4M | $232.0M | $122.5M | $113.3M |
| Total Current Liabilities | $1.83B | $2.21B | $1.81B | $1.47B | $1.60B | $1.08B | $310.3M | $246.5M |
| Long-Term Debt | $961.9M | $166.5M | $197.6M | $209.1M | $202.1M | $183.6M | $83.3M | $40.8M |
| Total Liabilities | $3.83B | $2.59B | $2.27B | $2.00B | $2.40B | $1.73B | $633.9M | $496.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-8.32B | $-8.61B | $-7.96B | $-7.08B | $-5.08B | $-3.55B | $-1.96B | $-1.01B |
| Total Stockholders' Equity | $4.36B | $3.33B | $3.54B | $4.38B | $6.13B | $3.87B | $962.2M | $1.74B |